For example, KLF9 has been shown to enhance the expression of PTEN, a well-characterized tumor suppressor, thereby inhibiting aerobic glycolysis and reducing chemotherapy resistance in breast cancer cells (16). This evidence concerns the gene KLF9 and breast carcinoma.